SuperworthCartesian Therapeutics market cap RNAC
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Oct 23, 2026
- $187M
- Highest close in our data
- $651M
- Jun 2024
Cartesian Therapeutics is worth $187M at the close on Oct 23, 2026, at $6.18 a share.
That is down 21% over the last year and down 55% over five years.
Its highest close in our data was $651M in Jun 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $187M | $155.1M | $311.2M | +8% |
| 2025 | $173.7M | $173.7M | $499.9M | −65% |
| 2024 | $503M | $71.9M | $651M | +370% |
| 2023 | $107M | $107M | $283.1M | −38% |
| 2022 | $172.9M | $102.9M | $375.7M | −55% |
| 2021 | $380.3M | $337.1M | $562.6M | +16% |
| 2020 | $327.3M | $113.3M | $369.5M | +197% |
| 2019 | $110.4M | $36.8M | $125.7M | +70% |
| 2018 | $65.1M | $65.1M | $350.5M | −70% |
| 2017 | $219.1M | $201.7M | $514.8M | −30% |
| 2016 | $312M | $199.7M | $478.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Cartesian Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| RNACCartesian Therapeutics | $187M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| ARVNArvinas | $477.3M |
| SPROSpero Therapeutics | $64.6M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Cartesian Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.